BNP Paribas Financial Markets’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.49M Buy
123,690
+115,972
+1,503% +$6.59M ﹤0.01% 1741
2026
Q1
$496K Sell
7,718
-44
-0.6% -$4.01K ﹤0.01% 3596
2025
Q4
$1.01M Buy
7,762
+1,244
+19% +$171K ﹤0.01% 3097
2025
Q3
$702K Buy
6,518
+673
+12% +$73.3K ﹤0.01% 3378
2025
Q2
$540K Sell
5,845
-478
-8% -$37.5K ﹤0.01% 3284
2025
Q1
$560K Sell
6,323
-50,265
-89% -$4.36M ﹤0.01% 3125
2024
Q4
$4.35M Buy
+56,588
New +$3.95M ﹤0.01% 1872

Other funds holding WGS

BNP Paribas Financial Markets's WGS Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its GeneDx Holdings (WGS) stake by 1,503% in Q2 2026, buying an estimated $6.59M and bringing the position to 123,690 shares worth $8.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

BNP Paribas Financial Markets first reported a position in WGS in Q4 2024 and has held it in 7 quarters since. 204 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • BNP Paribas Financial Markets held 123,690 shares of GeneDx Holdings worth $8.49M as of Q2 2026.
  • BNP Paribas Financial Markets bought 115,972 GeneDx Holdings shares in Q2 2026, an estimated $6.59M.
  • GeneDx Holdings made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1741 holding.
  • BNP Paribas Financial Markets first reported a position in GeneDx Holdings in Q4 2024 and has held it in 7 quarters since.
  • 204 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.